Predictors of Non-Response to Atezolizumab Plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: A Multicentre Real World Study (HCC-AB Study)
Journal of Clinical and Experimental Hepatology（2025）
Key words
Immune checkpoint inhibitors,HCC,PIVKA-II,Diabetes,ALBI score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined